Holen Sie sich die Stockscreener-App
18.57
2.49%
-0.487
Schlusskurs vom Vortag:
$19.06
Offen:
$19.05
24-Stunden-Volumen:
395.84K
Relative Volume:
0.17
Marktkapitalisierung:
$2.83B
Einnahmen:
$205.22M
Nettoeinkommen (Verlust:
$-121.24M
KGV:
-22.81
EPS:
-0.8141
Netto-Cashflow:
$-82.81M
1W Leistung:
+6.08%
1M Leistung:
+10.96%
6M Leistung:
+70.98%
1J Leistung:
+128.60%
1-Tages-Spanne:
$18.56
$19.10
1-Wochen-Bereich:
$16.55
$19.16
52-Wochen-Spanne:
$6.255
$20.76
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Firmenname
Adaptive Biotechnologies Corp
Sektor
Branche
Telefon
206-659-0067
Adresse
1165 EASTLAKE AVE E, SEATTLE, WA
Vergleichen Sie ADPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
18.57 | 2.91B | 205.22M | -121.24M | -82.81M | -0.8141 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.69 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.62 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
813.59 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.48 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.19 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2025-09-30 | Eingeleitet | Guggenheim | Buy |
| 2025-06-18 | Eingeleitet | Craig Hallum | Buy |
| 2025-03-21 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-21 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Underperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Neutral |
| 2022-02-16 | Bestätigt | BTIG Research | Buy |
| 2022-02-16 | Bestätigt | BofA Securities | Buy |
| 2022-02-16 | Bestätigt | Goldman | Neutral |
| 2022-02-16 | Bestätigt | JP Morgan | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-03-03 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Eingeleitet | Goldman | Buy |
| 2019-07-23 | Eingeleitet | BTIG Research | Buy |
| 2019-07-22 | Eingeleitet | BofA/Merrill | Buy |
| 2019-07-22 | Eingeleitet | Cowen | Outperform |
| 2019-07-22 | Eingeleitet | Goldman | Neutral |
| 2019-07-22 | Eingeleitet | Guggenheim | Buy |
| 2019-07-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 - The Manila Times
Hear Adaptive Biotechnologies' 2025 results live on Feb. 5 - Stock Titan
First Week of March 20th Options Trading For Adaptive Biotechnologies (ADPT) - Nasdaq
Sumitomo Mitsui Trust Group Inc. Trims Holdings in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Aug Selloffs: Will Adaptive Biotechnologies Corporation stock go up in YEARJuly 2025 Spike Watch & Comprehensive Market Scan Insights - baoquankhu1.vn
Adaptive Biotechnologies Insider Sold Shares Worth $1,411,131, According to a Recent SEC Filing - marketscreener.com
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 79,590 Shares of Stock - MarketBeat
Adaptive Biotechnologies’ Lo Francis sells $1.4m in shares By Investing.com - Investing.com India
Adaptive Biotechnologies’ Lo Francis sells $1.4m in shares - Investing.com
Adaptive Biotechnologies CFO Piskel sells $77,220 in shares - Investing.com
Adaptive Biotechnologies Exec Sells Shares - TradingView — Track All Markets
Assessing Adaptive Biotechnologies (ADPT) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Piper Sandler reiterates Overweight rating on Adeptus Biotechnologies stock By Investing.com - Investing.com Australia
What's Going On With Adaptive Biotechnologies Shares Tuesday? - Benzinga
Piper Sandler reiterates Overweight rating on Adeptus Biotechnologies stock - Investing.com
Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Revenue Growth Surges Over 100%, Analysts Eye 9.53% Upside - DirectorsTalk Interviews
Adaptive Biotechnologies Touts clonoSEQ MRD Growth, Targets Companywide Profitability in 2026 - Yahoo Finance
Adaptive Biotechnologies (ADPT) Surpasses Q4 Revenue Estimates, Shares Climb - GuruFocus
Adaptive Biotechnologies' Q4 Preliminary Revenue Rises 51%; Shares Jump in Premarket Trading - marketscreener.com
Adaptive Biotechnologies Rises 10% As Revenue Surges Over 50% - Nasdaq
Adaptive Biotechnologies reports 55% revenue growth in 2025 - Investing.com
Adaptive Biotechnologies reports 55% revenue growth in 2025 By Investing.com - Investing.com UK
Adaptive Biotechnologies announces preliminary fourth quarter and full year 2025 results - marketscreener.com
Adaptive Biotechnologies Reports Preliminary Financial Results for Q4 and Full Year 2025, Highlighting Significant Revenue Growth - Quiver Quantitative
Adaptive Biotechnologies stock soars after strong Q4 revenue beat - Investing.com
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results - The Manila Times
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells $164,400.00 in Stock - Defense World
Adaptive Biotechnologies Corporation $ADPT Holdings Trimmed by Peregrine Capital Management LLC - MarketBeat
Adaptive Biotechnologies CSO Robins sells $164k in shares By Investing.com - Investing.com India
Insider Sell: Harlan Robins Sells Shares of Adaptive Biotechnolo - GuruFocus
Adaptive Biotechnologies CSO Robins sells $164k in shares - Investing.com
Meme Stocks: Will Adaptive Biotechnologies Corporation (1HM) stock profit from automation waveMarket Movers & Smart Money Movement Alerts - Улправда
Adaptive Biotechnologies assumed with an Equal Weight at Morgan Stanley - MSN
Adaptive Biotechnologies Insider Sold Shares Worth $1,948,719, According to a Recent SEC Filing - marketscreener.com
Adaptive Biotechnologies’ Lo Francis sells $76,895 in shares By Investing.com - Investing.com Nigeria
Chad Robins Sells 124,998 Shares of Adaptive Biotechnologies Cor - GuruFocus
Adaptive Biotechnologies CEO Robins sells $1.95 million in shares - Investing.com
Adaptive Biotechnologies CEO Sells Over $1.9 Million in Company Stock - TradingView — Track All Markets
Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 6.7%Time to Buy? - MarketBeat
Adaptive Biotechnologies (ADPT) stock jumps as biotech gains; SEC filing flags insider sale - TechStock²
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Francis Lo Sells 3,125 Shares - MarketBeat
Adaptive Biotechnologies CPO Lo sells $50k in ADPT stock By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CPO Lo sells $50k in ADPT stock - Investing.com India
Adaptive Biotechnologies Corporation (ADPT) Stock Analysis: Unraveling Its 22.8% Potential Upside - DirectorsTalk Interviews
Adaptive Biotechnologies discloses it's raising $15 million for subsidiary - The Business Journals
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Biotech company heads to major healthcare conference in San Francisco - Stock Titan
Adaptive Biotechnologies announces subsidiary’s Series A financing round By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CorpUnit held initial closing $15 million Series A financingSEC filing - marketscreener.com
Adaptive Biotechnologies announces subsidiary’s Series A financing round - Investing.com
Finanzdaten der Adaptive Biotechnologies Corp-Aktie (ADPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.38%
1.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):